Quick Takeaways
- Dong Kim has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $493,809.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Dong Kim
- Location
- Princeton, NJ
- Summary
- The estimated net worth of Dong Kim is at least $493,809 dollars as of 27 Mar 2025. Dong Kim is the Chief Financial Officer of UroGen Pharma Ltd. and owns shares of UroGen Pharma Ltd. (URGN) stock worth about $493.8K.
- Signature
- /s/ Randy Milby as Attorney-In-Fact for Dong Kim
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Dong Kim and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: UroGen Pharma Ltd. ($493,809).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Dong Kim
URGN
Forms 3/4/5
UroGen Pharma Ltd.
- Relationship
- Chief Financial Officer
- Holdings value
- $493,809
- Past year net change
- Change %
- Report period
- 09 Sep 2024
CNTN
Forms 3/4/5
Tharimmune, Inc.
- Relationship
- Cfo
- Holdings value
- Past year net change
- Change %
- Report period
- 27 Mar 2025
Insider Transactions Reported by Dong Kim:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.